A subgroup analysis of the ODYSSEY APPRISE study: Safety and efficacy of alirocumab in the Italian cohort-Reference-Cited by-同舟云学术

A subgroup analysis of the ODYSSEY APPRISE study: Safety and efficacy of alirocumab in the Italian cohort

Published:2022-11 Issue:11 Volume:32 Page:2638-2646
ISSN:0939-4753
Container-title:Nutrition, Metabolism and Cardiovascular Diseases
language:en
Short-container-title:Nutrition, Metabolism and Cardiovascular Diseases

Author:

Cefalù Angelo B.,Garbelotto Raffaella,Mombelli Giuliana,Pirro Matteo,Rubba Paolo,Arca Marcello,Borghi Claudio,Bonomo Katia,Gonnelli Stefano,Massaroni Katia,Tirone Giampaolo,Averna Maurizio,Angelico Francesco,Cipollone Francesco,Corghi Enzo,Faggiano Pompilio,Greco Cesare,Guasti Luigina,Lucchi Tiziano,Sabba Carlo,Sarzani Riccardo,Terrosu Pierfranco,Zambon Alberto

Funder

Sanofi

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine,Nutrition and Dietetics,Endocrinology, Diabetes and Metabolism,Medicine (miscellaneous)

Reference30 articles.

1. 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk;Mach;Eur Heart J,2020

2. AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA guide- line on the management of blood cholesterol: executive summary: a report of the American college of cardiology/American heart association task force on clinical practice guidelines;Grundy;J Am Coll Cardiol,2018

3. On behalf of the American heart association council on epidemiology and prevention statistics committee and stroke statistics subcommittee. Heart disease and stroke statistics-2019 update: a report from the American heart association;Benjamin;Circulation,2019

4. National trends in total cholesterol obscure heterogeneous changes in HDL and non-HDL cholesterol and total-to-HDL cholesterol ratio: a pooled analysis of 458 population-based studies in Asian and Western countries;Int J Epidemiol,2019

5. Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980-2017: a systematic analysis for the Global Burden of Disease Study 2017;Lancet,2018

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. PCSK9 Inhibitors and Infection-Related Adverse Events: A Pharmacovigilance Study Using the World Health Organization VigiBase;Drugs - Real World Outcomes;2024-07-02